Daniel Tardiff
Vermogen: - $ op 31-05-2026
Vermogen: - $ op 31-05-2026
Daniel Tardiff is currently Chief Scientific Officer at CAMP4 Therapeutics Corp.
Dr. Tardiff worked as Research Head at Yumanity Therapeutics, Inc. Dr. Tardiff earned a doctorate from Brandeis University and completed undergraduate studies at Stonehill College, Inc.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-04-2026 | 0 ( -.--% ) | - $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| CAMP4 THERAPEUTICS CORPORATION | Hoofd Techniek/Wetenschap/O&O | 01-10-2025 |
| Bedrijven | Functie | Einde |
|---|---|---|
| YUMANITY THERAPEUTICS | Hoofd Techniek/Wetenschap/O&O | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Brandeis University
Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stonehill College, Inc.
Stonehill College, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Camp4 Therapeutics Corp.
Camp4 Therapeutics Corp. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in the development of regulatory RNA-based therapeutics | Health Technology |
Yumanity Therapeutics, Inc.
Yumanity Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau